Navigation path

Community Register of medicinal products

Community register of medicinal products for human use
AUTHORISED  

Product information
Invented name: Dificlir   
Auth. number : EU/1/11/733
INN : fidaxomicin
ATC: A - Alimentary tract and metabolism
A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents
A07A - Intestinal antiinfectives
A07AA - Antibiotics
A07AA12 - Fidaxomicin
(See WHO ATC Index)
Indication: DIFICLIR is indicated in adults for the treatment of Clostridium difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD)
Marketing Authorisation Holder: Astellas Pharma Europe B.V.
Sylviusweg 62, NL-2333 BE Leiden, Nederland

  EPAR and active package presentations

Package presentations

The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/12/2011 Centralised - Authorisation EMEA/H/C/2087 (2011)9174 of 05/12/2011
09/02/2012 Centralised - Transfer Marketing Authorisation Holder EMEA/H/C/2087/T/1 (2012)818 of 06/02/2012
29/06/2012 Centralised - Variation EMEA/H/C/2087/IAin/4/G
Updated with Decision(2012)7886 of 29/10/2012
29/06/2012 Centralised - Variation - (2012)4490 of 27/06/2012
29/06/2012 Centralised - Variation EMEA/H/C/2087/IA/3/G
Updated with Decision(2012)4490 of 27/06/2012
31/10/2012 Centralised - Variation - (2012)7886 of 29/10/2012
17/12/2012 Centralised - Variation EMEA/H/C/2087/IB/7
11/01/2013 Centralised - Variation EMEA/H/C/2087/IAin/8/G